When the Supreme Court overturned the Chevron doctrine on June 28, it ended the mandate that federal courts should defer to federal agencies’ interpretations when deciding on ambiguous statutes – which diminishes agency authority and shifts power to the courts, triggering ripple effects that could have widespread credit effects, according to Moody’s Investors Service.
SCOTUS’ overturning of Chevron to have credit effects in healthcare
